DANCAN — Dancann Pharma A/S Cashflow Statement
0.000.00%
Last trade - 00:00- DKK2.28m
- -DKK1.19m
- DKK7.76m
Annual cashflow statement for Dancann Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | DAS | DAS | DAS | DAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.25 | -11.8 | -16.1 | -62.3 | -9.59 |
| Non-Cash Items | 0.094 | 1.14 | 7.65 | 48.7 | 2.03 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.5 | -1.37 | -3.32 | 1.53 | -1.59 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.66 | -12 | -11.7 | -12 | -9.15 |
| Capital Expenditures | -18.8 | -32.4 | -8.27 | -4.04 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.322 | 0.155 | — | — | 0.001 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -19.1 | -32.2 | -8.27 | -4.04 | 0.001 |
| Financing Cash Flow Items | -4.67 | -0.668 | -5.74 | -1.27 | -6.14 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 47.9 | 30.6 | 23 | 7.33 | 10.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.1 | -13.6 | 3.02 | -8.74 | 1.46 |